A5101662716- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Eosinophilic Disorders and Syndromes
- Food Allergy and Anaphylaxis Research
- Dialysis and Renal Disease Management
- Drug-Induced Adverse Reactions
- SARS-CoV-2 and COVID-19 Research
- Food Safety and Hygiene
- Genetic factors in colorectal cancer
- Lymphatic System and Diseases
- Monoclonal and Polyclonal Antibodies Research
- Bone and Joint Diseases
- Immune Cell Function and Interaction
- COVID-19 Clinical Research Studies
- Histone Deacetylase Inhibitors Research
- Childhood Cancer Survivors' Quality of Life
- graph theory and CDMA systems
- Health, Nursing, Elderly Care
- Immunodeficiency and Autoimmune Disorders
- Eosinophilic Esophagitis
- COVID-19 Impact on Reproduction
- HIV-related health complications and treatments
Princess Margaret Cancer Centre
2022-2024
University of Toronto
2023-2024
Hospital Moinhos de Vento
2020-2023
University Health Network
2022
Universidade Federal do Rio Grande do Sul
2019
Hospital de Clínicas de Porto Alegre
2015-2017
Centro Hospitalar de Entre o Douro e Vouga E.P.E.
2014
The choice between an older matched sibling donor (MSD) and a younger unrelated (MUD) in allogeneic hematopoietic cell transplantation (HCT) remains subject of ongoing debate. In this single-center retrospective study 377 patients who received peripheral blood stem (PBSC) transplants for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), we compared outcomes 85 grafts from MSDs age >60 years 292 MUDs <30 years. Compared to recipients MSD transplants, MUD were more likely receive...
To assess clinical outcomes of intolerant, relapsed or refractory patients who could not be treated with new tyrosine kinase inhibitors experimental therapies.A retrospective cohort 90 chronic myeloid leukemia in all phases the disease imatinib mesylate as their first TKI therapy, and dasatinib nilotinib next line therapy. We evaluated these patients, special focus on group that needed more than two therapy lines.Thirty-nine percent were intolerant to imatinib. An 8-year overall survival...
The time elapsed from diagnosis to hematopoietic stem cell transplantation (HSCT) is influenced by numerous factors. In Brazil, patients using the public health system are also dependent on availability of HSCT-specific beds in hematology ward.
Cow’s milk protein allergy (CMPA) is the leading cause of food in children under three years age, although its gastrointestinal manifestations may occur all age groups. In suspicion CMPA based on anamnesis and physical examination, an elimination diet should be initiated for a variable length time according to clinical picture, followed by oral challenge (OFC) confi rming or excluding diagnosis. Complementary exams such as skin prick tests specifi c IgE necessary. Treatment demands...
Although extracorporeal photopheresis (ECP) is a promising second-line therapy in the treatment of chronic graft-versus-host disease (cGVHD), its use limited by high cost. This study aims to describe clinical evolution patients who underwent ECP for cGVHD and perform an economic analysis METHODS: was case series between 2016 2020 describing response micro-cost using time-driven activity-based costing.Six corticosteroid-dependent The cost per session 14,960.90 Brazilian reais (BRL), which...
Objective: The objective of this study was to estimate treatment costs Hematopoietic stem cell transplantation (HSCT) at a reference center in Brazil. Methods: population consisted patients from the Unified Health System HSCT who underwent southern Brazil between 2016 and 2019. Costs were measured using micro-costing approach, based on Time-Driven Activity-based Costing (TDABC) adapted for economic studies health included following steps: definition research question, structured data...